Fatigue - Blood
Research News and Information

Saturday, November 21, 2009

Carnitine plasma levels and fatigue in children/adolescents receiving cisplatin, ifosfamide, or doxorubicin.

30 Aug 2009 Fatigue is the most frequent symptom experienced by children/adolescents with cancer. One mechanism contributing to cancer-related fatigue involves abnormalities in adenosine triphosphate synthesis caused by carnitine deficiency. The purpose of this ... Read more...

Lactate and pH evaluation in exhausted humans with prolonged TASER X26 exposure or continued exertion.

15 Jun 2009 OBJECTIVE: Safety concerns about TASER Conducted Electrical Weapon (CEW) use and media reports of deaths after exposure have been expressed. CEWs are sometimes used on exhausted subjects to end resistance. The alternative is often a continued ... Read more...

DITPA (3,5-Diiodothyropropionic Acid), a thyroid hormone analog to treat heart failure: phase II trial veterans affairs cooperative study.

6 Jun 2009 BACKGROUND: In animal studies and a pilot trial in patients with congestive heart failure, the thyroid hormone analog 3,5 diiodothyropropionic acid (DITPA) had beneficial hemodynamic effects. METHODS AND RESULTS: This was a phase II multicenter, ... Read more...

Latest indexed articles for 'Fatigue - Blood'

These are the very latest articles for this heading:

• Carnitine plasma levels and fatigue in children/adolescents receiving cisplatin, ifosfamide, or doxorubicin. 30 Aug 2009
• Lactate and pH evaluation in exhausted humans with prolonged TASER X26 exposure or continued exertion. 15 Jun 2009
• DITPA (3,5-Diiodothyropropionic Acid), a thyroid hormone analog to treat heart failure: phase II trial veterans affairs cooperative study. 6 Jun 2009
• Using the differential from complete blood counts as a biomarker of fatigue in advanced non-small-cell lung cancer: an exploratory analysis. 30 May 2009
• Chronic fatigue of the small enterprise workers participating in an occupational health checkup center in southern Taiwan. 24 May 2009
• Fatigue resistance during high-intensity intermittent exercise from childhood to adulthood in males and females. 27 Apr 2009
• Effect of serum from overfatigue rats on JNK/c-Jun/HO-1 pathway in human umbilical vein endothelial cells and the intervening effect of Tongxinluo superfine powder. 27 Apr 2009
• Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue. 7 Apr 2009
• Ingestion of bonito extract ameliorates peripheral blood flow in mice loaded from over crowding stress. 30 Mar 2009
• Globus pallidus magnetization transfer ratio, T(1) and T(2) in primary biliary cirrhosis: relationship with disease stage and age. 30 Mar 2009
• Ordering blood tests for patients with unexplained fatigue in general practice: what does it yield? Results of the VAMPIRE trial. 30 Mar 2009
• Association of vital exhaustion and depressive symptoms with changes in fibrin D-dimer to acute psychosocial stress. 29 Mar 2009
• Changes in plasma and tissue amino acid levels in an animal model of complex fatigue. 9 Feb 2009
• Unfolding the mystery of the T-wave loop. 21 Jan 2009
• The impact of iron supplementation efficiency in female blood donors with a decreased ferritin level and no anaemia. Rationale and design of a randomised controlled trial: a study protocol. 14 Jan 2009
• The relation of testosterone levels with fatigue and apathy in Parkinson's disease. 6 Jan 2009
• Structural characterization and anti-fatigue activity of polysaccharides from the roots of Morinda officinalis. 23 Dec 2008
• Cardiac fatigue in long-distance runners is associated with ventricular repolarization abnormalities. 22 Dec 2008
• Testosterone levels in athletes at rest and exhaustion: effects of calcium supplementation. 18 Dec 2008
• Association of peripheral inflammatory markers with chronic fatigue in a population-based sample. 9 Dec 2008

See a longer list of these articles.

Technical information about 'Fatigue'

Definition: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.

Descriptor UI: D005221

Alternative terms: Fatigue; Lassitude;

Related Mesh Headings: Asthenia;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C23.888.369;

Technical Notes: do not use for fatigue of isolated muscle fibers in physiol exper ( = MUSCLE FATIGUE)